Nestlé Aims To Sell Unit for $10 Billion -- WSJ
May 17 2019 - 3:02AM
Dow Jones News
By Brian Blackstone and Ben Dummett
This article is being republished as part of our daily
reproduction of WSJ.com articles that also appeared in the U.S.
print edition of The Wall Street Journal (May 17, 2019).
ZURICH -- Nestlé SA has entered exclusive talks to sell its
skin-health business to private-equity firm EQT and the Abu Dhabi
Investment Authority for about $10.1 billion, the consumer-goods
giant's latest move to reshape its sprawling portfolio.
The Swiss company said in September it was exploring options for
the unit as part of a broader effort by Chief Executive Mark
Schneider to reinvigorate growth and focus more on coffee, pet care
and consumer health.
Nestlé said Thursday it expects to close the sale of the
skin-health business for 10.2 billion Swiss francs in the second
half of the year, at which point it would update investors on its
plans for the proceeds and its future capital structure.
The division, which includes face-care products Cetaphil and
Proactiv, generated net sales of 2.8 billion francs in 2018.
Nestlé, whose product mix also includes Purina pet food and Lean
Cuisine frozen meals, has annual sales of about 91 billion
francs.
Analysts at Vontobel Research said the price tag was at the high
end of its estimates. "In our model, we carried a price of 7
billion Swiss francs. However, we didn't rule out a price tag of up
to 10 billion Swiss francs," they said.
Nestlé established its skin-health unit in 2014 after taking
full control of Galderma, which added acne and skin-cancer
treatments to its portfolio. Nestlé said at the time it wanted to
take a more holistic approach to health than "mere nutrition" and
bolstered the unit with several acquisitions including a $1.4
billion deal for skin-care products from Valeant Pharmaceuticals
Inc. But as sales growth slowed, investors questioned how the unit
fits into Nestlé's broader business.
Founded in 1994 with the backing of Sweden's prominent
Wallenberg family, EQT has grown into one of Europe's largest
buyout firms with about EUR40 billion ($44.8 billion) in assets
under management, according to its website.
The EQT-led consortium's pricey pursuit of the Nestlé division
comes as private-equity firms in general are under pressure to
invest the record amounts of cash the industry has raised in recent
years from investors.
Carved-out businesses from a large company are attractive to
private-equity firms looking to deploy big amounts of cash quickly.
Such operations offer a growth opportunity for the buyer by
employing a dedicated management team and applying resources that
the business might not be getting as part of a larger entity.
Similar deals in Europe include KKR & Co.'s EUR6.83 billion
acquisition of Unilever PLC's margarine-and-spreads business in
2017 and the EUR10.1 billion purchase of the specialty chemicals
business of Akzo Nobel NV last year by a consortium led by Carlyle
Group LP.
Faced with pressure from activist investors two years ago,
Nestlé said it would focus its capital spending on high-growth
areas such coffee, pet care, and infant nutrition in a bid to
combat sluggish sales in a fast-changing consumer environment. And
its approach appears to be paying off. Last month, Nestlé reported
annual comparable sales growth of 3.4%, topping analyst
expectations. Its share price has gained 28% over the past 12
months.
Nestlé shares rose 1.8% to 100.42 francs on Thursday.
Last year, Nestlé sold its Gerber Life Insurance unit to Western
& Southern Financial Group for $1.55 billion in cash. It also
sold its U.S. confectionery business -- the maker of Butterfinger
and Baby Ruth candy bars -- to Ferrero International SA for $2.8
billion in cash.
Meanwhile, it has beefed up its coffee business. One year ago it
bought the rights to market and sell Starbucks coffee and tea
products in grocery and retail stores for more than $7 billion. In
2017, Nestlé bought a majority stake in U.S. premium coffee chain
Blue Bottle.
Late that year it also acquired Canadian vitamin maker Atrium
Innovations Inc. for $2.3 billion.
"Nestlé is well on track in successfully reshuffling its
portfolio, " the Vontobel analysts said Thursday.
--Anthony Shevlin in Barcelona contributed to this article.
Write to Brian Blackstone at brian.blackstone@wsj.com and Ben
Dummett at ben.dummett@wsj.com
(END) Dow Jones Newswires
May 17, 2019 02:47 ET (06:47 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
Nestle (PK) (USOTC:NSRGY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Nestle (PK) (USOTC:NSRGY)
Historical Stock Chart
From Apr 2023 to Apr 2024